+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immobilized Penicillin G Acylase Market - Global Forecast 2026-2032- Product Image
Immobilized Penicillin G Acylase Market - Global Forecast 2026-2032- Product Image
Sale

Immobilized Penicillin G Acylase Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127930
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immobilized Penicillin G Acylase Market is projected to reach USD 97.99 Million in 2026. It is expected to continue growing at a CAGR of 4.51%, reaching USD 124.10 Million by 2032.

Immobilized Penicillin G Acylase: Executive Overview

Immobilized penicillin G acylase is an enzyme-based biocatalyst used to convert penicillin G into 6-aminopenicillanic acid, an important intermediate for manufacturing semisynthetic penicillins. Immobilization supports enzyme recovery, repeated use, process control, and compatibility with continuous or semi-continuous production systems. Its relevance is closely tied to pharmaceutical quality requirements, bioprocess efficiency, catalyst stability, and reliable access to beta-lactam intermediates.

Bioprocessing Priorities Are Reshaping Enzyme Adoption

The landscape is shifting toward manufacturing systems that reduce solvent intensity, improve selectivity, and strengthen batch-to-batch consistency. Immobilized biocatalysts can support these objectives by enabling controlled reaction conditions and facilitating catalyst separation from process streams. Adoption decisions increasingly depend on carrier chemistry, enzyme loading, operational lifetime, regeneration practices, contamination control, and integration with downstream purification. Regulatory expectations for traceability and validated production are also encouraging more disciplined process design.

Artificial Intelligence Accelerates Process Optimization

Artificial intelligence can strengthen the development and operation of immobilized penicillin G acylase processes by identifying relationships among pH, temperature, substrate concentration, residence time, agitation, and catalyst activity. Machine-learning models can help prioritize enzyme variants, carrier formulations, and operating windows before laboratory testing. In manufacturing, anomaly detection may identify activity loss, fouling, or drift earlier than conventional monitoring. These tools do not replace experimental validation: reliable deployment requires representative datasets, explainable models, cybersecurity controls, and documented links between algorithmic recommendations and quality decisions.

Regional Insights: Capacity, Regulation, and Supply Resilience

North America emphasizes advanced bioprocessing, quality systems, and resilient pharmaceutical supply chains. Latin America presents opportunities linked to regional medicine production but requires attention to technical skills, imported inputs, and validation infrastructure. Europe combines strong pharmaceutical regulation with established interest in sustainable chemistry and process intensification. The Middle East is developing life-science and manufacturing capabilities, making technology transfer and workforce development important. Africa’s priorities include dependable access to essential medicines, local production capability, and practical maintenance support. Asia-Pacific remains central to pharmaceutical intermediate manufacturing, with varied regulatory environments and substantial demand for scalable, cost-efficient biocatalytic operations.

Group Insights: Trade, Regulation, and Manufacturing Alignment

ASEAN economies can benefit from regional pharmaceutical integration, although standards, technical capacity, and cross-border logistics vary among members. BRICS countries span major manufacturing, research, and medicine-supply systems, creating opportunities for collaboration while also highlighting differences in regulation and infrastructure. The European Union supports harmonized quality expectations and sustainability-oriented manufacturing practices. G7 economies generally contribute advanced research, validation expertise, and high-compliance production capabilities. GCC members are strengthening healthcare and industrial diversification agendas, increasing the importance of local skills and technology partnerships. NATO members include diverse pharmaceutical systems, so cooperation is most relevant to supply-chain resilience, preparedness, and shared quality principles rather than a uniform market structure.

Country Insights Across Major Pharmaceutical Systems

Australia combines stringent quality expectations with a research-oriented biomanufacturing base. Brazil’s large healthcare system and industrial capacity make local process robustness important. Canada emphasizes regulated production, research collaboration, and supply continuity. China has extensive pharmaceutical manufacturing capabilities and is advancing process modernization. France, Germany, Italy, and Spain operate within European regulatory frameworks while retaining distinct industrial and research strengths. India’s broad pharmaceutical sector supports strong interest in efficient intermediate production and scalable biocatalysis. Japan prioritizes precision manufacturing, quality assurance, and process reliability. Mexico’s proximity to North American supply chains makes technical standardization and production resilience significant. Russia’s pharmaceutical development is shaped by domestic supply considerations and regulatory requirements. South Korea combines advanced biomanufacturing capabilities with strong quality and technology-development practices. The United Kingdom maintains substantial life-science expertise and a rigorous regulatory environment. The United States emphasizes innovation, validated manufacturing, and secure pharmaceutical supply networks.

Priorities for Leaders: Validate, Digitize, and De-Risk Operations

Industry leaders should first define the target process around measurable outcomes such as catalyst productivity, reuse cycles, impurity control, recovery efficiency, and total process reliability. They should compare immobilization supports using standardized durability and leaching tests, then validate performance under representative feedstock and scale conditions. Digital monitoring should combine inline or at-line measurements with statistically controlled operating ranges rather than relying on opaque automation. Supply resilience can be improved through qualified backup sources for enzymes, carriers, and critical equipment. Finally, cross-functional teams spanning process development, quality, engineering, procurement, and regulatory affairs should govern scale-up decisions and document lifecycle performance.

Research Methodology: Evidence-Based Market Interpretation

This executive summary interprets the specified market scope as immobilized penicillin G acylase and synthesizes verifiable implications from established principles of enzymatic biocatalysis, pharmaceutical manufacturing, immobilization science, quality management, and regional industrial conditions. The analysis distinguishes technical capabilities from adoption considerations and avoids unsupported numerical claims. Regional, group, and country observations are framed as qualitative context, reflecting differences in regulation, manufacturing maturity, research capacity, supply-chain priorities, and healthcare production systems. Conclusions should be supplemented with primary interviews, validated plant data, regulatory documentation, and application-specific process trials before investment or commercialization decisions.

Conclusion: Biocatalyst Performance Must Translate into Validated Value

Immobilized penicillin G acylase remains strategically relevant where pharmaceutical producers seek selective conversion, catalyst recovery, controlled processing, and more resource-efficient manufacture of penicillin intermediates. Its practical value depends less on enzyme selection alone than on the full system: immobilization chemistry, reactor configuration, feed quality, downstream separation, monitoring, and quality validation. Organizations that combine rigorous experimentation with responsible digital optimization and resilient sourcing will be better positioned to convert biocatalytic capability into dependable pharmaceutical production.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Immobilized Penicillin G Acylase Market, by Carrier Type
7.1. Introduction
7.2. Inorganic Silica
7.3. Magnetic Nanoparticles
7.4. Organic Polymer
7.4.1. Natural Polymer
7.4.1.1. Alginate
7.4.1.2. Chitosan
7.4.2. Synthetic Polymer
7.4.2.1. Polyacrylamide
7.4.2.2. Polystyrene
7.5. Resin
8. Immobilized Penicillin G Acylase Market, by Immobilization Method
8.1. Introduction
8.2. Adsorption
8.3. Covalent Binding
8.3.1. Chemical Cross-Linking
8.3.2. Spacer Arm Techniques
8.4. Cross-Linking
8.5. Encapsulation
8.6. Entrapment
9. Immobilized Penicillin G Acylase Market, by Process Type
9.1. Introduction
9.2. Batch Process
9.3. Continuous Process
9.3.1. Fluidized Bed Reactor
9.3.2. Packed Bed Reactor
10. Immobilized Penicillin G Acylase Market, by Enzyme Source
10.1. Introduction
10.2. Recombinant Strains
10.2.1. Bacillus Subtilis
10.2.2. Escherichia Coli
10.3. Wild Strains
11. Immobilized Penicillin G Acylase Market, by Product Form
11.1. Introduction
11.2. Beads
11.2.1. Gel Beads
11.2.2. Porous Beads
11.3. Granules
11.4. Powder
12. Immobilized Penicillin G Acylase Market, by Application
12.1. Introduction
12.2. Beta-Lactam Antibiotics Production
12.2.1. Amoxicillin Production
12.2.2. Ampicillin Production
12.2.3. Novel Beta-Lactam Synthesis
12.3. Cephalosporin Production
13. Immobilized Penicillin G Acylase Market, by End Use Industry
13.1. Introduction
13.2. Contract Manufacturing Organizations
13.3. Diagnostics
13.4. Food Processing
13.5. Pharmaceutical Manufacturing
13.5.1. Generic Manufacturing
13.5.2. Innovator Manufacturing
14. Immobilized Penicillin G Acylase Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Immobilized Penicillin G Acylase Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Immobilized Penicillin G Acylase Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Amano Enzyme Inc.
18.2. Biocatalysts Ltd.
18.3. Codexis, Inc.
18.4. Creative Enzymes Co., Ltd.
18.5. EnzymeWorks (Suzhou) Co., Ltd.
18.6. Nakai Chemicals Co., Ltd.
18.7. Novozymes A/S
18.8. Royal DSM N.V.
18.9. Sanzyme Biologics Limited
18.10. Shandong Lukang Pharmaceutical Co., Ltd.
18.11. Sichuan Deebio Pharmaceutical Co., Ltd.
18.12. Zhejiang Konson Biotech Co., Ltd.
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Immobilized Penicillin G Acylase Market, Years Considered for the Study
FIGURE 2. Global Immobilized Penicillin G Acylase Market, Research Design
FIGURE 3. Global Immobilized Penicillin G Acylase Market, Research Framework
FIGURE 4. Global Immobilized Penicillin G Acylase Market, Data Triangulation
FIGURE 5. Global Immobilized Penicillin G Acylase Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2025 vs 2032 (%)
FIGURE 7. Global Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2025 vs 2032 (%)
FIGURE 9. Global Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Immobilized Penicillin G Acylase Market Size, by Process Type, 2025 vs 2032 (%)
FIGURE 11. Global Immobilized Penicillin G Acylase Market Size, by Process Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2025 vs 2032 (%)
FIGURE 13. Global Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Immobilized Penicillin G Acylase Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 15. Global Immobilized Penicillin G Acylase Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Immobilized Penicillin G Acylase Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Immobilized Penicillin G Acylase Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2025 vs 2032 (%)
FIGURE 19. Global Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Immobilized Penicillin G Acylase Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Immobilized Penicillin G Acylase Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Immobilized Penicillin G Acylase Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Immobilized Penicillin G Acylase Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Immobilized Penicillin G Acylase Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Immobilized Penicillin G Acylase Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Immobilized Penicillin G Acylase Market Segmentation & Coverage
TABLE 2. Global Immobilized Penicillin G Acylase Market Size, 2017-2032 (USD Million)
TABLE 3. Global Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 4. Global Inorganic Silica Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Inorganic Silica Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Inorganic Silica Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Magnetic Nanoparticles Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Magnetic Nanoparticles Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Magnetic Nanoparticles Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Organic Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Organic Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Organic Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Natural Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Natural Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Natural Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Alginate Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Alginate Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Alginate Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Chitosan Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Chitosan Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Chitosan Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Synthetic Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Synthetic Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Synthetic Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Polyacrylamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Polyacrylamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Polyacrylamide Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Polystyrene Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Polystyrene Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Polystyrene Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Resin Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Resin Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Resin Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 35. Global Adsorption Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Adsorption Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Adsorption Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Covalent Binding Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Covalent Binding Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Covalent Binding Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Chemical Cross-Linking Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Chemical Cross-Linking Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Chemical Cross-Linking Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Spacer Arm Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Spacer Arm Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Spacer Arm Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Cross-Linking Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cross-Linking Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cross-Linking Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Encapsulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Encapsulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Encapsulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Entrapment Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Entrapment Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Entrapment Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 57. Global Batch Process Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Batch Process Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Batch Process Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Continuous Process Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Continuous Process Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Continuous Process Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Fluidized Bed Reactor Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Fluidized Bed Reactor Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Fluidized Bed Reactor Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Packed Bed Reactor Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Packed Bed Reactor Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Packed Bed Reactor Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 70. Global Recombinant Strains Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Recombinant Strains Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Recombinant Strains Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Bacillus Subtilis Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Bacillus Subtilis Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Bacillus Subtilis Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Escherichia Coli Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Escherichia Coli Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Escherichia Coli Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Wild Strains Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Wild Strains Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Wild Strains Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 83. Global Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Beads Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Gel Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Gel Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Gel Beads Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Porous Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Porous Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Porous Beads Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Granules Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Global Beta-Lactam Antibiotics Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Beta-Lactam Antibiotics Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Beta-Lactam Antibiotics Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Amoxicillin Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Amoxicillin Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Amoxicillin Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Ampicillin Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Ampicillin Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Ampicillin Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Novel Beta-Lactam Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Novel Beta-Lactam Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Novel Beta-Lactam Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Cephalosporin Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Cephalosporin Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Cephalosporin Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 115. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Food Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Food Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Food Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Pharmaceutical Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Pharmaceutical Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Pharmaceutical Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Generic Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Generic Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Generic Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Innovator Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Innovator Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Innovator Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 151. North America Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. North America Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 153. North America Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 154. North America Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 155. North America Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 156. North America Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 157. North America Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 158. North America Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 159. North America Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 160. North America Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 161. North America Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 162. North America Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 163. North America Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 164. North America Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. North America Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 166. North America Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 167. North America Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 168. Latin America Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Latin America Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 170. Latin America Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 171. Latin America Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 172. Latin America Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 173. Latin America Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 174. Latin America Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 175. Latin America Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 176. Latin America Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 177. Latin America Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 178. Latin America Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 179. Latin America Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 180. Latin America Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 181. Latin America Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Latin America Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 183. Latin America Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 184. Latin America Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 185. Europe Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Europe Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 187. Europe Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 188. Europe Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 189. Europe Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 190. Europe Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 191. Europe Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 192. Europe Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 193. Europe Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 194. Europe Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 195. Europe Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 196. Europe Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 197. Europe Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 198. Europe Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Europe Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 200. Europe Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 201. Europe Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 202. Middle East Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Middle East Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 204. Middle East Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 205. Middle East Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 206. Middle East Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 207. Middle East Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 208. Middle East Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 209. Middle East Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 210. Middle East Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 211. Middle East Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 212. Middle East Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 213. Middle East Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 214. Middle East Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 215. Middle East Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Middle East Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 217. Middle East Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 218. Middle East Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 219. Africa Immobilized Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Africa Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 221. Africa Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 222. Africa Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 223. Africa Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 224. Africa Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 225. Africa Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 226. Africa Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 227. Africa Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 228. Africa Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 229. Africa Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 230. Africa Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 231. Africa Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 232. Africa Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Africa Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 234. Africa Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 235. Africa Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 236. Global Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. ASEAN Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. ASEAN Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 239. ASEAN Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 240. ASEAN Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 241. ASEAN Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 242. ASEAN Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 243. ASEAN Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 244. ASEAN Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 245. ASEAN Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 246. ASEAN Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 247. ASEAN Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 248. ASEAN Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 249. ASEAN Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 250. ASEAN Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. ASEAN Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 252. ASEAN Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 253. ASEAN Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 254. GCC Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. GCC Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 256. GCC Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 257. GCC Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 258. GCC Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 259. GCC Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 260. GCC Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 261. GCC Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 262. GCC Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 263. GCC Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 264. GCC Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 265. GCC Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 266. GCC Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 267. GCC Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. GCC Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 269. GCC Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 270. GCC Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 271. European Union Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. European Union Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 273. European Union Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 274. European Union Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 275. European Union Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 276. European Union Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 277. European Union Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 278. European Union Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 279. European Union Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 280. European Union Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 281. European Union Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 282. European Union Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 283. European Union Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 284. European Union Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. European Union Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 286. European Union Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 287. European Union Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 288. BRICS Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. BRICS Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 290. BRICS Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 291. BRICS Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 292. BRICS Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 293. BRICS Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 294. BRICS Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 295. BRICS Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 296. BRICS Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 297. BRICS Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 298. BRICS Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 299. BRICS Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 300. BRICS Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 301. BRICS Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. BRICS Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 303. BRICS Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 304. BRICS Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 305. G7 Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. G7 Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 307. G7 Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 308. G7 Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 309. G7 Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 310. G7 Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 311. G7 Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)
TABLE 312. G7 Immobilized Penicillin G Acylase Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 313. G7 Immobilized Penicillin G Acylase Market Size, by Continuous Process, 2017-2032 (USD Million)
TABLE 314. G7 Immobilized Penicillin G Acylase Market Size, by Enzyme Source, 2017-2032 (USD Million)
TABLE 315. G7 Immobilized Penicillin G Acylase Market Size, by Recombinant Strains, 2017-2032 (USD Million)
TABLE 316. G7 Immobilized Penicillin G Acylase Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 317. G7 Immobilized Penicillin G Acylase Market Size, by Beads, 2017-2032 (USD Million)
TABLE 318. G7 Immobilized Penicillin G Acylase Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. G7 Immobilized Penicillin G Acylase Market Size, by Beta-Lactam Antibiotics Production, 2017-2032 (USD Million)
TABLE 320. G7 Immobilized Penicillin G Acylase Market Size, by End Use Industry, 2017-2032 (USD Million)
TABLE 321. G7 Immobilized Penicillin G Acylase Market Size, by Pharmaceutical Manufacturing, 2017-2032 (USD Million)
TABLE 322. NATO Immobilized Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 323. NATO Immobilized Penicillin G Acylase Market Size, by Carrier Type, 2017-2032 (USD Million)
TABLE 324. NATO Immobilized Penicillin G Acylase Market Size, by Organic Polymer, 2017-2032 (USD Million)
TABLE 325. NATO Immobilized Penicillin G Acylase Market Size, by Natural Polymer, 2017-2032 (USD Million)
TABLE 326. NATO Immobilized Penicillin G Acylase Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 327. NATO Immobilized Penicillin G Acylase Market Size, by Immobilization Method, 2017-2032 (USD Million)
TABLE 328. NATO Immobilized Penicillin G Acylase Market Size, by Covalent Binding, 2017-2032 (USD Million)

Companies Mentioned

  • Amano Enzyme Inc.
  • Biocatalysts Ltd.
  • Codexis, Inc.
  • Creative Enzymes Co., Ltd.
  • EnzymeWorks (Suzhou) Co., Ltd.
  • Nakai Chemicals Co., Ltd.
  • Novozymes A/S
  • Royal DSM N.V.
  • Sanzyme Biologics Limited
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Sichuan Deebio Pharmaceutical Co., Ltd.
  • Zhejiang Konson Biotech Co., Ltd.

Related Topics

Related Reports

Penicillin G Acylase Market - Global Strategic Business Report - Product Image

Penicillin G Acylase Market - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Penicillin Active Pharmaceutical Ingredients Market - Global Forecast 2026-2032 - Product Image

Penicillin Active Pharmaceutical Ingredients Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 185 Pages
  • Global
From
Penicillin Active Pharmaceutical Ingredients Market Report 2026 - Product Image

Penicillin Active Pharmaceutical Ingredients Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.